New hope for kids with rare muscle disease: drug trial launches
NCT ID NCT06607627
First seen Feb 03, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study tests a drug called gefurulimab in 12 children aged 6 to 18 who have generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see how the drug moves through the body, how well it works, and if it is safe. Participants will receive the drug and be monitored for 18 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGWashington D.C., District of Columbia, 20010, United States
-
Research Site
RECRUITINGNorfolk, Virginia, 23507, United States
-
Research Site
RECRUITINGJoinville, 89202-451, Brazil
-
Research Site
RECRUITINGSalvador, 41253-190, Brazil
-
Research Site
RECRUITINGSão José do Rio Preto, 15090-000, Brazil
-
Research Site
RECRUITINGSão Paulo, 0438-002, Brazil
-
Research Site
RECRUITINGSão Paulo, 05403-000, Brazil
-
Research Site
RECRUITINGSaitama-Shi, 330-8777, Japan
-
Research Site
WITHDRAWNBydgoszcz, 85-065, Poland
-
Research Site
WITHDRAWNLodz, 93-338, Poland
-
Research Site
RECRUITINGWarsaw, 02-097, Poland
-
Research Site
RECRUITINGNew Taipei City, 23561, Taiwan
-
Research Site
RECRUITINGTaipei, 11101, Taiwan
Conditions
Explore the condition pages connected to this study.